NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: North-West University, South Africa
Conditions: Cardiovascular Diseases, Hypertension, Health Risk Behaviors, Arterial Stiffness, Young
Countries: South Africa
The African-PREDICT study aims to (i) generate new knowledge on the early pathophysiology accompanying hypertension development in black South Africans; and (ii) to identify early novel markers or predictors for the development of hypertension and cardiovascular outcome. By employing also in Africa the latest cutting-edge scientific technologies to measure single and multiple biomarkers proven to predict hypertension and cardiovascular outcome (such as multiplex analyses, proteomics and metabolomics), precision medicine may have the potential to lead to novel strategies in preventing and treating hypertension in Africa.
Sex: ALL
Age: 20 Years to 30 Years
Healthy volunteers: Yes
Study type: OBSERVATIONAL
Inclusion Criteria: * Brachial BP \<140 and 90 mmHg * HIV uninfected * No previous diagnosis or medication for chronic disease * Not pregnant or breastfeeding Exclusion Criteria: * Planning to move away from the Potchefstroom area in the next 5 years * Currently pregnant or breastfeeding * Sick on the day of appointment * Lack the ability to read or understand English * Diagnosed with HIV, Cancer, Tuberculosis, Diabetes, Hypertension, Liver or Kidney disease, Heart disease * Previously had a heart attack or stroke * Have suffered a recent trauma or had surgery in the past 3 months * Have a phobia for needles * Have donated blood in the previous 3 months * Taking chronic medication (Anti-inflammatory, for Hypertension of Diabetes, Cortisone, Anti-Retroviral, Thyroid medication, Cholesterol medication)
- Potchefstroom, North West, South Africa